Reimagining U.S. Drug Policy Post-Pandemic

Ohio State Legal Studies Research Paper No. 684

Drug Enforcement and Policy Center, No. 43, February 2022

10 Pages Posted: 22 Feb 2022 Last revised: 1 Mar 2022

See all articles by Samuel DeWitt

Samuel DeWitt

Ohio State University (OSU), Michael E. Moritz College of Law, Students

Date Written: February 17, 2022

Abstract

The COVID-19 pandemic caused increased drug use and a widespread decline in mental health throughout American society. Yet, despite the unprecedented pandemic, society as a whole has shown an impressive ability to adapt to new ways of living, suggesting that a dramatically different version of America is not only possible, but achievable. Domestic drug policy, which has needlessly prohibited and criminalized a vast array of drugs since the early 1900s, is an area ripe for a similar dramatic change. This paper explores how the pandemic, combined with concurrent events including a change in Federal Administration and nationwide protests against systemic racism, presents an opportunity for our country to rethink its long-standing drug prohibition on a national scale.

Keywords: COVID, pandemic, drugs, drug policy, protests, legalization, War on Drugs

Suggested Citation

DeWitt, Samuel, Reimagining U.S. Drug Policy Post-Pandemic (February 17, 2022). Ohio State Legal Studies Research Paper No. 684, Drug Enforcement and Policy Center, No. 43, February 2022, Available at SSRN: https://ssrn.com/abstract=4037600 or http://dx.doi.org/10.2139/ssrn.4037600

Samuel DeWitt (Contact Author)

Ohio State University (OSU), Michael E. Moritz College of Law, Students ( email )

55 West 12th Avenue
Columbus, OH 43210
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
150
Abstract Views
710
Rank
351,306
PlumX Metrics